These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 24931777)

  • 21. Early post-operative ACTH and cortisol as predictors of remission in Cushing's disease.
    Acebes JJ; Martino J; Masuet C; Montanya E; Soler J
    Acta Neurochir (Wien); 2007; 149(5):471-7; discussion 477-9. PubMed ID: 17406780
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Previous radiotherapy negatively influences quality of life during 4 years of follow-up in patients cured from acromegaly.
    van der Klaauw AA; Biermasz NR; Hoftijzer HC; Pereira AM; Romijn JA
    Clin Endocrinol (Oxf); 2008 Jul; 69(1):123-8. PubMed ID: 18182092
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The development of the Tuebingen Cushing's disease quality of life inventory (Tuebingen CD-25). Part I: construction and psychometric properties.
    Milian M; Teufel P; Honegger J; Gallwitz B; Schnauder G; Psaras T
    Clin Endocrinol (Oxf); 2012 Jun; 76(6):851-60. PubMed ID: 21801193
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gender differences in presentation and outcome of patients with Cushing's disease in Han Chinese.
    Huan C; Qu Y; Ren Z
    Biomed Mater Eng; 2014; 24(6):3439-46. PubMed ID: 25227055
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Personality characteristics and quality of life in patients treated for Cushing's syndrome.
    Sonino N; Bonnini S; Fallo F; Boscaro M; Fava GA
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):314-8. PubMed ID: 16487442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Similar psychopathological profiles in female and male Cushing's disease patients after treatment but differences in the pathogenesis of symptoms.
    Milian M; Honegger J; Gerlach C; Hemeling X; Psaras T
    Neuroendocrinology; 2014; 100(1):9-16. PubMed ID: 24902887
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcomes after repeat transsphenoidal surgery for recurrent Cushing's disease.
    Patil CG; Veeravagu A; Prevedello DM; Katznelson L; Vance ML; Laws ER
    Neurosurgery; 2008 Aug; 63(2):266-70; discussion 270-1. PubMed ID: 18797356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bilateral adrenalectomy in Cushing's disease: Altered long-term quality of life compared to other treatment options.
    Sarkis P; Rabilloud M; Lifante JC; Siamand A; Jouanneau E; Gay E; Chaffanjon P; Chabre O; Raverot G
    Ann Endocrinol (Paris); 2019 Feb; 80(1):32-37. PubMed ID: 30243473
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Subtle cognitive impairments in patients with long-term cure of Cushing's disease.
    Tiemensma J; Kokshoorn NE; Biermasz NR; Keijser BJ; Wassenaar MJ; Middelkoop HA; Pereira AM; Romijn JA
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2699-714. PubMed ID: 20371667
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Affected illness perceptions and the association with impaired quality of life in patients with long-term remission of acromegaly.
    Tiemensma J; Kaptein AA; Pereira AM; Smit JW; Romijn JA; Biermasz NR
    J Clin Endocrinol Metab; 2011 Nov; 96(11):3550-8. PubMed ID: 21917873
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
    Mukherjee A; Murray RD; Teasdale GM; Shalet SM
    Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The hypercoagulable state in Cushing's disease is associated with increased levels of procoagulant factors and impaired fibrinolysis, but is not reversible after short-term biochemical remission induced by medical therapy.
    van der Pas R; de Bruin C; Leebeek FW; de Maat MP; Rijken DC; Pereira AM; Romijn JA; Netea-Maier RT; Hermus AR; Zelissen PM; de Jong FH; van der Lely AJ; de Herder WW; Lamberts SW; Hofland LJ; Feelders RA
    J Clin Endocrinol Metab; 2012 Apr; 97(4):1303-10. PubMed ID: 22278425
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Persistent negative illness perceptions despite long-term biochemical control of acromegaly: novel application of the drawing test.
    Tiemensma J; Pereira AM; Romijn JA; Broadbent E; Biermasz NR; Kaptein AA
    Eur J Endocrinol; 2015 May; 172(5):583-93. PubMed ID: 25724922
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcome of Cushing's disease following transsphenoidal surgery in a single center over 20 years.
    Hassan-Smith ZK; Sherlock M; Reulen RC; Arlt W; Ayuk J; Toogood AA; Cooper MS; Johnson AP; Stewart PM
    J Clin Endocrinol Metab; 2012 Apr; 97(4):1194-201. PubMed ID: 22278423
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictive factors for neurocognitive function and Quality of Life after surgical treatment for Cushing's disease and acromegaly.
    Psaras T; Milian M; Hattermann V; Will BE; Tatagiba M; Honegger J
    J Endocrinol Invest; 2011; 34(7):e168-77. PubMed ID: 21060251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Affective alterations in patients with Cushing's syndrome in remission are associated with decreased BDNF and cortisone levels.
    Valassi E; Crespo I; Keevil BG; Aulinas A; Urgell E; Santos A; Trainer PJ; Webb SM
    Eur J Endocrinol; 2017 Feb; 176(2):221-231. PubMed ID: 27932530
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quality of life in Cushing's syndrome.
    Santos A; Crespo I; Aulinas A; Resmini E; Valassi E; Webb SM
    Pituitary; 2015 Apr; 18(2):195-200. PubMed ID: 25647329
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuropsychiatric and cardiometabolic comorbidities in patients with previously diagnosed Cushing's disease: a longitudinal observational study.
    Dimopoulou C; Geraedts V; Stalla GK; Sievers C
    BMJ Open; 2015 Mar; 5(3):e006134. PubMed ID: 25818269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A cross-sectional study to investigate long-term cognitive function in people with treated pituitary Cushing's disease.
    Heald A; Parr C; Gibson C; O'driscoll K; Fowler H
    Exp Clin Endocrinol Diabetes; 2006 Oct; 114(9):490-7. PubMed ID: 17115346
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic and cardiovascular outcomes in patients with Cushing's syndrome of different aetiologies during active disease and 1 year after remission.
    Giordano R; Picu A; Marinazzo E; D'Angelo V; Berardelli R; Karamouzis I; Forno D; Zinnà D; Maccario M; Ghigo E; Arvat E
    Clin Endocrinol (Oxf); 2011 Sep; 75(3):354-60. PubMed ID: 21521323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.